Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / C•••••••• C•••••••

S••••••• S•••••• Acquires C•••••••• C•••••••, Amplifying Patient Recruitment Capabilities

Add-on acquisitionannouncedadd-onannouncement date unknownFact
What happened
Platform
S••••••• S••••••add-on basis: This is the second acquisition S••••••• has completed since its strategic partnership with K••• L••• in 2023. | published on K••• L•••'s own news page
Control
Control
Share acquired
unknown
Industry
healthcare / clinic
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • This is the second acquisition S••••••• has completed since its strategic partnership with K••• L••• in 2023. | published on K••• L•••'s own news page
  • This is the second acquisition S••••••• has completed since its strategic partnership with K••• L••• in 2023. | published on K••• L•••'s own news page
Side not stated
  • “We are thrilled to welcome the extraordinarily talented and established C•••••••• C••••••• team to S••••••• and cannot wait to see what we’re able to accomplish together as a unified and powerful force in the patient recruitment space,” said J••••••• W•••••, CEO of S••••••• S••••••.
  • “We are delighted to join the S••••••• team and feel fortunate to have found a partner with capabilities and culture that marry so perfectly with our own,” said N••• W••••••, president of C•••••••• C•••••••.
  • S••••••• S••••••, an independent, integrated healthcare and scientific marketing, communications, media and strategic services firm focused on the pharmaceutical, biotech and broader life science industries, today announced the acquisition of C•••••••• C•••••••, a global clinical trial recruitment a
Evidence
S••••••• S••••••, an independent, integrated healthcare and scientific marketing, communications, media and strategic services firm focused on the pharmaceutical, biotech and broader life science industries, today announced the acquisition of C•••••••• C•••••••, a global clinical trial recruitment and engagement solutions provider with a 30-year track record of success elevating interest, increasing access and enhancing experiences in clinical trials.
S••••••• S•••••• Acquires C•••••••• C•••••••, Amplifying Patient Recruitment Capabilities | Private Equity Intelligence | DFX